Best Dividend Stocks To Buy According To Cliff Asness’ Aqr Capital Management

0

AQR Capital Management co-founder Cliff Asness is a well-known financial analyst. One of the first quantitative funds in the United States, AQR is a pioneer in the field. With a current real-time net worth of $1.4 billion as of January 2022, Asness is a very wealthy businessman. The 13F portfolio of Cliff Asness’ AQR Capital Management has a value of $54 billion. Market trends are monitored and a portfolio is constructed using algorithms at a hedge fund. An 11.17 percent 2013 return was followed by 16.15 percent 2014 and a 17.03 percentage point 2015 return by the Long-Short Equity Fund of the fund.

Insider Monkey focuses on the dividend stocks in Cliff Asness’ portfolio. The quarterly dividend of AbbVie Inc. was raised by nine percent to $1.41 per share on October 27. Members of the S&P 500’s Dividend Aristocrats Index are companies with a record of dividend growth of at least 25 years. 3M Company is one of Cliff Asness’ top dividend-paying stocks. There have been dividends paid to shareholders for the past 100 years, and the company has maintained an impressive 63-year streak of dividend growth. For the past five years, AQR Capital Management has invested in 3M. A total of 74 hedge funds monitored by Insider Monkey reported holding shares of the company in the third quarter. Over $2.66 billion has been invested in these investments. The quarterly dividend of Pfizer Inc. has been increased by 2.6% to $0.40 per share. Shares worth $28.5 million were purchased by AQR Capital Management in the fourth quarter of 2010. PepsiCo, Inc. was worth $292.2 million to the hedge fund as of the third quarter of 2021. Merck has an 11-year track record of dividend growth, and the company’s dividend growth rate in the past five years was 7.4 percent. The company has increased its quarterly dividend by 6.2 percent to $0.69 per share. For more details, click the 10 Best Dividend Stocks To Buy According To Cliff Asness’ Aqr Capital Management.

 

Share.